The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Pediatric Rare Diseases — A Collaborative Approach for Drug Development Using Gaucher Disease as a Model



The purpose of this guidance is to facilitate drug development in pediatric rare diseases.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information